Physician profile
Heather D Dolasinski
NPI 1548608490
$2,606.81
in general payments reported to CMS, 2019-2025
7 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $23.03 · 2021: $157 · 2022: $437 · 2023: $434 · 2024: $1,098 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,232 · Travel and Lodging: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,231.58 |
| Travel and Lodging | $517.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,129.59 | 2022-2025 | Total30, Hydrus Microstent, Precision7 |
| Johnson & Johnson Vision Care, INC. | $707.87 | 2019-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $236.52 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $179.04 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $134.02 | 2022-2024 | |
| Coopervision INC. | $132.58 | 2019-2023 | Myday Contact Lens |
| Biotissue Holdings INC. | $87.19 | 2023-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Dolasinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.